In hospital |
Aspirin (%) | 98.9 | 97.7 | 94.3 |
Clopidogrel (%) | 47.9 | 73.6 | 66.6 |
Beta-blocker (%) | 82.6 | 83.0 | 85.1 |
Angiotensin-converting enzyme inhibitors (%) | 74.0 | 64.3 | 60.0 |
Angiotensin II receptor blockers (%) | 1.7 | 4.3 | 8.9 |
Nitrate (%) | 37.7 | 53.5 | 61.7 |
Diuretics (%) | 13.9 | 22.1 | 18.4 |
Ca blockers (%) | 3.6 | 10.8 | 15.1 |
Statin (%) | 96.7 | 94.5 | 92.7 |
Fibrate (%) | 0.3 | 0.6 | 0.3 |
Ezitimibe (%) | 2.3 | 1.7 | 0.3 |
Digoxin (%) | 0.4 | 0.8 | 0.6 |
Unfractionated heparin (%) | 8.4 | 2.0 | 0.9 |
Low-molecular-weight heparin (%) | 79.5 | 91.2 | 89.7 |
Glycoprotein IIb/IIIa inhibitor (%) | 25.5 | 66.3 | 26.0 |
Warfarin (%) | 1.7 | 1.0 | 1.9 |
Insulin (%) | 19.6 | 19.1 | 19.8 |
Oral hypoglycaemic agent (%) | 13.6 | 20.7 | 21.4 |
Predischarge exercise stress test (%) | 0.5 | 0.5 | 3.3 |
In-hospital coronary angiogram (%) | 51.4 | 58.4 | 49.1 |
At hospital discharge |
Aspirin (%) | 96.3 | 94.4 | 88.7 |
Clopidogrel (%) | 45.1 | 66.8 | 52.4 |
Beta-blocker (%) | 84.7 | 82.7 | 84.1 |
Angiotensin-converting enzyme inhibitors (%) | 71.1 | 62.1 | 57.4 |
Angiotensin II receptor blockers (%) | 1.8 | 4.5 | 9.2 |
Nitrate (%) | 13.2 | 23.5 | 30.0 |
Diuretics (%) | 11.2 | 19.7 | 18.1 |
Ca blockers (%) | 4.1 | 9.5 | 16.1 |
Statin (%) | 95.0 | 93.0 | 87.1 |
Fibrate (%) | 0.5 | 0.3 | 0.6 |
Ezitimibe (%) | 2.0 | 2.0 | 1.3 |
Digoxin (%) | 0.4 | 0.5 | 0.6 |
Warfarin (%) | 1.3 | 0.6 | 1.6 |
Insulin (%) | 4.3 | 5.5 | 7.9 |
Oral hypoglycaemic agent (%) | 23.0 | 29.4 | 31.3 |